epa11622466 Novo Nordisk CEO Lars Jorgensen testifies before the Senate Health, Education, Labor and Pensions Committee hearing on 'Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?' on Capitol Hill in Washington, DC, USA, 24 September 2024. EPA/SHAWN THEW
USA SENATE NOVO NORDISK
USA SENATE NOVO NORDISK
epa11622466 Novo Nordisk CEO Lars Jorgensen testifies before the Senate Health, Education, Labor and Pensions Committee hearing on 'Why Is Novo Nordisk Charging Americans with Diabetes and Obesity Outrageously High Prices for Ozempic and Wegovy?' on Capitol Hill in Washington, DC, USA, 24 September 2024. EPA/SHAWN THEW
foto SHAWN THEW
FotoID: HN:20240924715935
Samo prijavljeni korisnici mogu preuzeti fotografiju u punoj kvaliteti.
Izvor:
EPA
Foto:
SHAWN THEW